Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 27 of 58, showing 10 Applications out of 576 total, starting on record 261, ending on 270

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

261.

ECCT/18/12/01   study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants.
    A Phase 1b, open-label, age de-escalation, dose-escalation study to evaluate the safety and immunogenicity of different doses of a candidate malaria vaccine; adjuvanted R21(R21/MM) in adults, young children and infants in Kilifi, Kenya.   
Principal Investigator(s)
1. Mainga Hamaluba
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
19-03-2019 View

262.

ECCT/15/11/04   VAC040
    A Phase 1/2, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Tolerability, and Immunogenicity of Stretococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide (PATH-wSP) in Healthy Kenya Young Adults (18 - 40years) and Toddlers (12 - 19months)   
Principal Investigator(s)
1. John Anthony Gerard Scott
Site(s) in Kenya
KEMRI-Wellcome Trust Research Program
 
09-02-2016 View

263.

ECCT/14/02/03  
    A Phase 1/2 Randomized, Double-Blind, Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated  Streptococcus pneumoniae Whole Cell Vaccine Formulated with Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers (12-15 Months of Age)       
Principal Investigator(s)
1. Nekoye Namungu Otsyula
2. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Kombewa Clinical Research Center
 
14-02-2014 View

264.

ECCT/23/11/04   AUB Study
    A phase 1, single-center, double-blind, randomized, placebo-controlled trial to assess the safety, tolerability and initial efficacy of AHC01 delivered via transcervical catheter in adult females (25-55 years), experiencing abnormal uterine bleeding and scheduled for a hysterectomy.   
Principal Investigator(s)
1. Dr Alice Kaaria
Site(s) in Kenya
Kenyatta National Hospital (KNH)
 
15-04-2024 View

265.

ECCT/25/07/01   FIH Study of CLY-124
    A Phase 1, Randomized, Placebo-Controlled, Double Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CLY-124 in Healthy Volunteers and Participants with Sickle Cell Disease   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. Strathmore University Medical Center [SUMC], Creates for Research in Therapeutic Sciences (Nairobi City county)
2. Victoria Biomedical Research Institute [VIBRI] (Kisumu county)
 
18-12-2025 View

266.

ECCT/25/08/09   First-in-human (FIH) study
    A Phase 1, Randomized, Placebo-Controlled, Double Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CLY-124 in Healthy Volunteers and Participants with Sickle Cell Disease   
Principal Investigator(s)
1. Dr Lucas Tina Otieno
Site(s) in Kenya
1. Victoria Biomedical Research Institute [VIBRI] (Kisumu county)
2. Strathmore University Medical Center [SUMC], Creates for Research in Therapeutic Sciences (Nairobi City county)
 
17-09-2026 View

267.

ECCT/20/06/09   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa   
Principal Investigator(s)
1. Professor Walter Jaoko, Jaoko,
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. KEMRI/ Wellcome Trust Research Programme (Kilifi county)
 
09-09-2020 View

268.

ECCT/20/10/01   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa.    
Principal Investigator(s)
1. Eduard J Sanders
Site(s) in Kenya
1. KEMRI Mtwapa Research Clinic (Kilifi county)
2. KAVI-ICR Nairobi (Nairobi City county)
 
19-11-2020 View

269.

ECCT/21/06/04   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Lucas Otieno
Site(s) in Kenya
1. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Murang\'a county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
02-08-2021 View

270.

ECCT/21/06/06   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. KEMRI CCR-Butere County Hospital Site (Kakamega county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Nairobi City county)
7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
8. Moi University Clinical Research Centre (Uasin Gishu county)
9. Aga Khan University Hospital (Nairobi City county)
10. Kenya Medical Research Institute (Kisumu county)
11. KEMRI/Walter Reed Project Research Center (Kericho county)
12. Ganjoni Clinic (Mombasa county)
13. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
14. Kenya Medical Research Institute (Nairobi City county)
15. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
16. Moi University Clinical Research Centre (Uasin Gishu county)
17. Aga Khan University Hospital (Nairobi City county)
18. Kenya Medical Research Institute (Kisumu county)
19. KEMRI/Walter Reed Project Research Center (Kericho county)
20. Ganjoni Clinic (Mombasa county)
21. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
22. Kenya Medical Research Institute (Nairobi City county)
23. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
24. Moi University Clinical Research Centre (Uasin Gishu county)
25. Aga Khan University Hospital (Nairobi City county)
26. Kenya Medical Research Institute (Kisumu county)
27. KEMRI/Walter Reed Project Research Center (Kericho county)
28. Ganjoni Clinic (Mombasa county)
29. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
30. Kenya Medical Research Institute (Nairobi City county)
31. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
32. Moi University Clinical Research Centre (Uasin Gishu county)
33. Aga Khan University Hospital (Nairobi City county)
34. Kenya Medical Research Institute (Kisumu county)
35. KEMRI/Walter Reed Project Research Center (Kericho county)
36. Ganjoni Clinic (Mombasa county)
37. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
38. Kenya Medical Research Institute (Nairobi City county)
39. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
40. Moi University Clinical Research Centre (Uasin Gishu county)
41. Aga Khan University Hospital (Nairobi City county)
 
16-08-2021 View